NFL Biosciences SA (FR:ALNFL)

:ALNFL

ALNFL

NFL Biosciences SA

RESEARCH TOOLSreports

NFL Biosciences SA (ALNFL) Price & Analysis

1 Followers

ALNFL Stock Chart & Stats

€1.30

-€0.02(-1.28%)

At close: Jan 09 4:00 PM EST

€1.30

-€0.02(-1.28%)

Day’s Range― - ―

52-Week Range€0.84 - €1.85

Previous CloseN/A

Volume1.86K

Average Volume (3M)55.03K

Market Cap

€11.24M

Enterprise Value€11.58M

Total Cash (Recent Filing)€3.56M

Total Debt (Recent Filing)€72.73K

Price to Earnings (P/E)―

Beta1.34

Next Earnings

Oct 27, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.54

Shares Outstanding12,672,242

10 Day Avg. Volume45,311

30 Day Avg. Volume55,026

Financial Highlights & Ratios

PEG Ratio0.17

Price to Book (P/B)19.83

Price to Sales (P/S)421000.26

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)-0.21

Revenue Forecast (FY)N/A

NFL Biosciences SA News

NFL Biosciences Unveils 2025 Financial Agenda

An announcement from NFL Biosciences SA ( ($FR:ALNFL) ) is now available. NFL Biosciences has announced its financial...

1y ago

NFL Biosciences Confirms NFL-101’s Superior Safety in New Study

The latest announcement is out from NFL Biosciences SA ( ($FR:ALNFL) ). NFL Biosciences announced positive results from...

1y ago

ALNFL FAQ

What was NFL Biosciences SA’s price range in the past 12 months?

NFL Biosciences SA lowest stock price was €0.84 and its highest was €1.85 in the past 12 months.

What is NFL Biosciences SA’s market cap?

NFL Biosciences SA’s market cap is €11.24M.

When is NFL Biosciences SA’s upcoming earnings report date?

NFL Biosciences SA’s upcoming earnings report date is Oct 27, 2026 which is in 136 days.

How were NFL Biosciences SA’s earnings last quarter?

NFL Biosciences SA released its earnings results on Apr 15, 2026. The company reported -€0.12 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.12.

Is NFL Biosciences SA overvalued?

According to Wall Street analysts NFL Biosciences SA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does NFL Biosciences SA pay dividends?

NFL Biosciences SA does not currently pay dividends.

What is NFL Biosciences SA’s EPS estimate?

NFL Biosciences SA’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does NFL Biosciences SA have?

NFL Biosciences SA has 12,672,242 shares outstanding.

What happened to NFL Biosciences SA’s price movement after its last earnings report?

NFL Biosciences SA reported an EPS of -€0.12 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.399%.

Which hedge fund is a major shareholder of NFL Biosciences SA?

Currently, no hedge funds are holding shares in FR:ALNFL

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

NFL Biosciences SA

Established in 2006 and headquartered in Castelnau-le-Lez, France, NFL Biosciences S.A. is a biotechnology enterprise dedicated to pioneering natural remedies for addiction cessation, particularly for individuals seeking to quit smoking. Their most advanced therapeutic candidate, NFL-101, derived from tobacco, is currently progressing through Phase III clinical trials specifically designed to combat smoking addiction. Additionally, the company's research pipeline features NFL-201, an extract blending cannabis and tobacco, and NFL-301, a botanical formulation rooted in traditional Chinese medicine, both of which are undergoing preclinical assessment.